Journal of Medicinal Chemistry · 2012 · 37 citations · 23 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingProtein StructureProtein-ligand RecognitionProteolytic EnzymesActive Site ResiduesAspartic ProteasesBeta Secretase InhibitionEnzyme Inhibitor DiscoveryProtease SelectivityProtein-ligand Complex StructureProtein-ligand ComplexesSelectivity
The structure-based design, synthesis, and X-ray structure of protein-ligand complexes of exceptionally potent and selective β-secretase inhibitors are described. The inhibitors are designed specifically to interact with S(1)' active site residues to provide selectivity over memapsin 1 and cathepsin D. Inhibitor 5 has exhibited exceedingly potent inhibitory activity (K(i) = 17 pM) and high selectivity over BACE 2 (>7000-fold) and cathepsin D (>250000-fold). A protein-ligand crystal structure revealed important molecular insight into these selectivities. These interactions may serve as an important guide to design selectivity over the physiologically important aspartic acid proteases.
23
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong Lin, Gerald Koelsch, Xinli Lin et al. · Science · 2000 · 706 citations